Ascentage Pharma’s Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLL

GlobeNewswire Inc. | Oct 20, 2026 7:30 PM EDT

Lisa granted breakthrough designation for Lisa in China